Novel heart failure drug could halt disease progression
Heart failure drug acoramidis could increase survival rates in transthyretin…
Heart failure drug acoramidis could increase survival rates in transthyretin amyloid cardiomyopathy (ATTR-CM), Phase III study data suggests.